Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease – In conversation with…

Michael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease.

Read the full article here

Related Articles